Atnaujinkite slapukų nuostatas

Clinical Aspects of Psychopharmacology in Childhood & Adolescence [Kietas viršelis]

Edited by , Edited by , Edited by , Edited by , Edited by
  • Formatas: Hardback, 310 pages, aukštis x plotis: 260x180 mm, weight: 766 g
  • Išleidimo metai: 01-Dec-2016
  • Leidėjas: Nova Science Publishers Inc
  • ISBN-10: 1536102415
  • ISBN-13: 9781536102413
Kitos knygos pagal šią temą:
  • Formatas: Hardback, 310 pages, aukštis x plotis: 260x180 mm, weight: 766 g
  • Išleidimo metai: 01-Dec-2016
  • Leidėjas: Nova Science Publishers Inc
  • ISBN-10: 1536102415
  • ISBN-13: 9781536102413
Kitos knygos pagal šią temą:
Dedication ix
Professor Hatim A Omar
Foreword xi
Introduction 1(2)
Chapter 1 Pediatric psychopharmacology: Perspectives of history
3(30)
Donald E Greydanus
Joav Merrick
Section one Attention deficit hyperactivity disorder
33(48)
Chapter 2 Attention deficit hyperactivity disorder: Pharmacologic management in children and adolescents
35(26)
Gabriel Kaplan
Jeffrey H Newcorn
Iliyan S Ivanov
Chapter 3 Attention deficit hyperactivity disorder and comorbid substance abuse
61(20)
Iliyan Ivanov
Andrew Pearson
Gabriel Kaplan
Jeffrey Newcorn
Section two Mental health aspects
81(90)
Chapter 4 Psychotherapy in the age of pharmacology
83(10)
Helen D Pratt
Chapter 5 Depression: Major depressive and dysthymic disorders
93(10)
Joseph L Calles, Jr.
Ahsan Nazeer
Chapter 6 Pediatric bipolar disorder
103(14)
Ahsan Nazeer
Joseph L Calles, Jr.
Chapter 7 Anxiety disorders in children and adolescents
117(12)
Dilip R Patel
Kelly A. Brown
Donald E Greydanus
Chapter 8 Oppositional defiant and conduct disorders
129(8)
Joseph L Calles, Jr.
Ahsan Nazeer
Chapter 9 Control of aggression and violence
137(12)
Joseph L Calles, Jr.
Ahsan Nazeer
Chapter 10 Tic disorders in children and adolescents: Principles of psychopharmacologic management
149(22)
Donald E Greydanus
Section three Specific disorders
171(44)
Chapter 11 Autism spectrum disorders
173(18)
Ahsan Nazeer
Joseph L Calles, Jr.
Chapter 12 Schizophrenia in children and adolescents
191(14)
Ahsan Nazeer
Joseph L Calles, Jr.
Chapter 13 Cognitive-adaptive disabilities
205(10)
Joseph L Calles, Jr.
Ahsan Nazeer
Section four Other use
215(62)
Chapter 14 Sleep disorders in children and adolescents
217(36)
Donald E Greydanus
Chapter 15 Pharmacological agents for smoking cessation
253(8)
Dilip R Pate
Donald E Greydanus
Chapter 16 Substance use disorders in adolescents: Pharmacologic management
261(16)
Donald E Greydanus
Section five Conclusion
277(14)
Chapter 17 Pediatric psychopharmacology: Quo vadis, where do we go from here?
279(12)
Donald E Greydanus
Joav Merrick
Section six Acknowledgements
291(14)
Chapter 18 About the Editors
293(2)
Chapter 19 About the Department of Pediatric and Adolescent Medicine, Western Michigan University Homer Stryker MD School of Medicine (WMED), Kalamazoo, Michigan USA
295(2)
Chapter 20 About the National Institute of Child Health and Human Development in Israel
297(4)
Chapter 21 About the book series "Pediatrics, child and adolescent health"
301(4)
Section seven Index
305(2)
Index 307